IO Biotech to participate in panel discussion at BIO-Europe Spring in Amsterdam on March 12, 2018

Feb 20, 2018

Copenhagen, Denmark – February 20, 2018: IO Biotech’s CEO, Mai-Britt Zocca, is to participate in the panel discussion “The Harrods Food Hall problem in immuno-oncology” at the partnering conference BIO-Europe Spring in Amsterdam on March 12, 2018.

Other news

IO Biotech, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

IO Biotech, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

November 9, 2021
IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 with KEYTRUDA® (pembrolizumab) as First-Line Treatment in Metastatic Melanoma Patients in a Phase 3 Trial

IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 with KEYTRUDA® (pembrolizumab) as First-Line Treatment in Metastatic Melanoma Patients in a Phase 3 Trial

September 14, 2021
back to news overview